Interferon induced psoriatic arthritis in a patient with renal cancer;Interferon által indukált arthritis psoriatica vesecarcinomás betegben

Orvosi Hetilap

Volumn 146, Issue 49, 2005, Pages 2503-2506

  Gaál, János ^a,c   Kálmánchey, Judit ^a   Szegedi, Andrea ^b   Szabó, Béla ^a   Surányi, Péter ^a  

^a Kenezy Korhaz Rendelointezet   (Hungary)

^b UNIVERSITY OF DEBRECEN   (Hungary)

^c Urológiai Osztály ^*  (Hungary)

Author keywords

Interferon treatment; Psoriatic arthritis; Renal cancer

Indexed keywords

ALPHA INTERFERON; DISEASE MODIFYING ANTIRHEUMATIC DRUG; NONSTEROID ANTIINFLAMMATORY AGENT; STEROID; ALPHA2A INTERFERON; ANTINEOPLASTIC AGENT;

ARTICLE; AUTOIMMUNE THYROIDITIS; DRUG EFFECT; DRUG WITHDRAWAL; HUMAN; INFERIOR CAVA VEIN; KIDNEY CANCER; LABORATORY DIAGNOSIS; METASTASIS; NEPHRECTOMY; POLYARTHRITIS; PSORIATIC ARTHRITIS; TREATMENT OUTCOME; ADJUVANT CHEMOTHERAPY; ADULT; CASE REPORT; CHEMICALLY INDUCED DISORDER; FEMALE; KIDNEY TUMOR; REVIEW;

ADULT; ANTINEOPLASTIC AGENTS; ARTHRITIS, PSORIATIC; CHEMOTHERAPY, ADJUVANT; FEMALE; HUMANS; INTERFERON ALFA-2A; KIDNEY NEOPLASMS; NEPHRECTOMY; THYROIDITIS, AUTOIMMUNE;

EID: 33644868341     PISSN: 00306002     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (36)

1. Andriani, A., Bibas, M., Callea, V. és mtsai: Autoimmune hemolytic anaemia during alpha interferon treatment in nine patients with hematological diseases. Hematologica, 1996, 81, 258-260.
2. Ariad, S., Song, E., Cohen, R. és mtsa: Interferon-alpha induced autoimmune hepatitis in a patient with Philadelphia chromosome-positive chronic myeloid leukemia with cytogenetically normal T lymphocytes. Mol. Biother., 1992, 4, 139-142.
3. Billiau, A., Heremans, H., Vermie, K. és mtsa: Immunmodulatory properties of interferon-gamma. An update. Ann. N. Y. Acad. Sci., 1998, 856, 22-32.
4. Bito, T., Roy, S., Sen, C. K. és mtsa: Pine bark extract pycnogenol downregulates IFN-gamma-induced adhesion of T cells to human keratinocytes by inhibiting inducible ICAM-1 expression. Free Radic. Biol. Med., 2000, 28, 219-227.
5. Bonnekoh, B., Bockelmann, R., Ambach, A. és mtsa: Dithranol and dimethylfumarate suppress the interferon-gamma-induced upregulation of cytokeratin 17 as a putative psoriasis autoantigen in vitro. Skin Pharmacol. Appl. Skin Physiol., 2001, 14, 217-225.
6. Chung, A., Older, S. A.: Interferon-a associated arthritis. J. Rheumatol., 1997, 24, 1844-1845.
7. Fahal, I. H., Murry, N., Chu, P. és mtsa: Acute renal failure during interferon treatment. Brit. Med. J., 1993, 306, 973.
8. Germain, P., Delbrel, X., Traissac, T. és mtsai: Psoriatic rheumatism in a patient taking interferon-alpha, reversible with treatment cessation. Presse Med., 1999, 228, 2226.
9. Goldstein, D., László, J.: Interferon therapy in cancer: From imagination to interferon. Cancer Res., 1986, 46, 4315-4329.
10. Jucgla, A., Marcoval, J., Curco, N. és mtsa: Psoriasis with articular involvement induced by interferon alfa. Arch. Dermatol., 1991, 127, 910-911.
11. Kirsner, R. S., Anhalt, G. J., Kerdel, F. A.: Treatment with alpha interferon associated with the development of paraneoplastic pemphigus. Br. J. Dermatol., 1995, 132, 474-478.
12. Koh, L. K., Greenspan, F. S., Yeo, P. P.: Interferon-alpha induced thyroid dysfunction: Three clinical presentations and a review of the literature. Thyroid, 1997, 7, 891-896.
13. Lacotte, L., Thierry, A., Delvail, V. és mtsa: Thrombotic thrombocytopenic purpura during interferon alpha treatment for chronic myelogenous leukemia. Acta Hematol., 2000, 102, 160-162.
14. Lensch, E., Faust, J., Nix, W. A. és mtsa: Myasthenia gravis after interferon-alpha treatment. Muscle Nerve, 1996, 19, 927-928.
15. Levesque, M. C. Ward, F. E., Jeffery, D. R. és mtsa: Interferon-β1A-induced polyarthritis in a patient with the HLA-DRB1*0404 allele. Arthritis Rheum., 1999, 42, 569-573.
16. th ed. Wiliams & Wilkins, Baltimore. 1996, 439-478. old.
17. Makino, Y., Tanaka, H., Nakamura, K. és mtsai: Arthritis in a patient with psoriasis after interferon-a therapy for chronic hepatitis C. J. Rheumatol., 1994, 21, 1771-1772.
18. McLaughlin, P., Talpaz, M., Quesada, J. R. és mtsai: Immune thrombocytopenia following alpha-interferon therapy in patients with cancer. J. Am. Med. Ass., 1985, 25, 1353-1354.
19. Mee, J. B., Alam, Y., Groves, R. W.: Human keratinocytes constitutively produce but do not process interleukin 18. Br. J. Dermatol, 2000, 143, 330-336.
20. Nesher, G., Ruchlemer, R.: Alpha-interferon-induced arthritis: Clinical presentation, treatment, and prevention. Semin. Arthritis Rheum., 1998, 27, 360-365.
21. Nishibu, A., Han, G. W., Iwatsuki, K. és mtsai: Overexpression of monocyte-derived cytokines in active psoriasis: a relation to coexistent arthropathy. J. Dermatol. Sci., 1999, 21, 63-70.
22. O'Connel, P. G., Gerber, L. H., Digiovanna, J. J. és mtsa: Arthritis in patients with psoriasis treated with gamma interferon. J. Rheumatol., 1992, 19, 80-82.
23. Olivieri, I., Pandula, A., Ciancio, G. és mtsa: Psoriatic arthritis and alpha interferon. Scand. J. Rheumatol., 2001, 31, 175.
24. Pecoriari, P.: Ulcerative colitis in hairy cell leukemia. A case report. Recenti. Prog. Med., 1991, 82, 269-271.
25. Pietropauli, A., Modrak, J., Utell, M.: Interferon alpha therapy associated with the developement of sarcoidosis. Chest, 1999, 116, 569-572.
26. Quesada, J. R., Talpaz, M., Rios, A. és mtsai: Clinical toxicity of interferons in cancer patients: A review. J. Clin. Oncol., 1986, 4, 234-243.
27. Raanani, P., Ben-Bassat, I.: Immune-mediated complications during interferon therapy in hematological patients. Acta Haematol., 2002, 107, 133-144.
28. Ramseur, J. T., Richard, F. 2nd, Duggan, D. B.: A case of fatal pemphigus vulgaris in association with beta interferon and interleukin-2 therapy. Cancer, 1989, 63, 2005-2007.
29. Roy, V., Newland, A. C.: Raynaud's phenomenon and cryoglobulinaemia associated with the use of recombinant human alpha-interferon. Lancet, 1988, 1, 944-945.
30. Sacchi, S., Kantarijan, H., O'Brien, S. és mtsai: Immune-mediated and unusual complications during interferon alfa therapy in chronic myelogenous leukemia. J. Clin. Oncol., 1995, 13, 2401-2407.
31. Schilling P. J., Kurzrock, R., Kantarijan, H. és mtsai: Development of systemic lupus erythematosus after interferon therapy for chronic myelogenous leukemia. Cancer, 1991, 68, 1536-1537.
32. Segawa, E, Shimizu, Y., Saito, E. és mtsa: Bechcet's disease induced by interferon therapy for chronic myelogenous leukemia. J. Rheumatol., 1995, 22, 1183-1184.
33. Souza, E. P., Segundo, P. T, E., José, F. F. és mtsai: Rheumatoid arthritis induced by a-interferon therapy. Clin. Rheumatol., 2001, 20, 297-299.
34. Sztein, M. B., Steeg, P. S., Johnson, H. M. és mtsa: Regulation of human peripheral blood monocyte DR antigen expression in vitro by lymphokines and recombinant interferon. J. Clin. Invest., 1984, 73, 556-565.
35. Ueno, Y., Sohma, T.: Alpha-interferon-induced nodular rheumatoid arthritis in renal cell carcinoma (letter). Ann Intern Med, 1992, 117, 266-267.
36. Yamaoka, J., Sasaki, M., Miyachi, Y.: Ultraviolet B radiation downregulates inducible nitric oxide synthase expression induced by interferon-gamma or tumor necrosis factor-alpha in murine keratinocyte Pam 212 cells. Arch. Dermatol. Res., 2000, 292, 312-319.